antibody-drug conjugates
Gilead’s $5 Billion Bet Targets Tubulis’ Potential Best-in-Class ADC Platform in Oncology Push
2026-04-07
Precision Oncology in Focus at ESMO 2025: New Data Across Rare Cancers, CML, and Solid Tumors
2025-10-20
Next-Gen Biotech Innovation Driving Cancer Therapy Genomics, AI-Powered Trials, and APAC’s Global Rise at BIO Asia-Taiwan 2025
2025-07-23
South Korean Biotech Command Global Spotlight at BIO 2025 with Dynamic Pavilion & Strategic Alliances
2025-06-23
HoneyBear Biosciences Gets Gold: First to Publish ARC Research in Asia & Wins ‘Best ADC Developer in Taiwan’ at 2025 ABEA
2025-03-13
LATEST
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan







